| Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease A Égerházi, R Berecz, E Bartók, I Degrell Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (3), 746-751, 2007 | 265 | 2007 |
| CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers P Dorado, R Berecz, MJ Norberto, Ü Yasar, ML Dahl, A LLerena European journal of clinical pharmacology 59, 221-225, 2003 | 131 | 2003 |
| QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations A Llerena, R Berecz, P Dorado, A De la Rubia Journal of psychopharmacology 18 (2), 189-193, 2004 | 107 | 2004 |
| Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions A LLerena, P Dorado, R Berecz, AP González, EM Peñas-LLedó European journal of clinical pharmacology 59, 869-873, 2004 | 100 | 2004 |
| Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients JA Carrillo, SI Ramos, AG Herraiz, A Llerena, JAG Agundez, R Berecz, ... Journal of clinical psychopharmacology 19 (6), 494-499, 1999 | 94 | 1999 |
| Cognitive functions in prepsychotic patients E Bartók, R Berecz, T Glaub, I Degrell Progress in Neuro-Psychopharmacology and Biological Psychiatry 29 (4), 621-625, 2005 | 89 | 2005 |
| Antibiotic use in 3 European university hospitals RA Kiivet, ML Dahl, A Llerena, M Maimets, B Wettermark, R Berecz Scandinavian journal of infectious diseases 30 (3), 277-280, 1998 | 81 | 1998 |
| The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions R Berecz, P Dorado, ADL Rubia, MC Caceres, I Degrell, A LLerena Current drug targets 5 (6), 573-579, 2004 | 74 | 2004 |
| QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients A LLerena, R Berecz, A de la Rubia, P Dorado Journal of psychopharmacology 16 (4), 361-364, 2002 | 73 | 2002 |
| Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients A LLerena, P Dorado, R Berecz, A González, MJ Norberto, A de la Rubia, ... Journal of Chromatography B 783 (1), 25-31, 2003 | 69 | 2003 |
| Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype R Berecz, A de la Rubia, P Dorado, P Fernández-Salguero, ML Dahl, ... European journal of clinical pharmacology 59, 45-50, 2003 | 68 | 2003 |
| Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions A LLerena, R Berecz, P Dorado, CS de la Garza, MJ Norberto, M Cáceres, ... Journal of Chromatography B 783 (1), 213-219, 2003 | 60 | 2003 |
| Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes A LLerena, R Berecz, A de la Rubia, P Fernández-Salguero, P Dorado Therapeutic drug monitoring 23 (6), 616-620, 2001 | 56 | 2001 |
| Investigating the state-like and trait-like characters of social cognition in schizophrenia: a short term follow-up study N Balogh, A Égerházi, R Berecz, G Csukly Schizophrenia Research 159 (2-3), 499-505, 2014 | 51 | 2014 |
| Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients R Berecz, A LLerena, A De La Rubia, J Gomez, M Kellermann, P Dorado, ... Pharmacopsychiatry 35 (06), 231-234, 2002 | 51 | 2002 |
| Reduced completed suicide rate in Hungary from 1990 to 2001: relation to suicide methods R Berecz, M Cáceres, A Szlivka, P Dorado, E Bartók, E Penas-LLedó, ... Journal of affective disorders 88 (2), 235-238, 2005 | 49 | 2005 |
| Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity A Llerena, R Berecz, A de la Rubia, MJ Norberto, J Benítez Therapeutic drug monitoring 22 (4), 397-401, 2000 | 49 | 2000 |
| P300 in mild cognitive impairment and in dementia A Egerházi, T Glaub, P Balla, R Berecz, I Degrell Psychiatria Hungarica: A Magyar Pszichiátriai Társaság Tudományos Folyóirata …, 2008 | 48 | 2008 |
| Pharmacogenetics of clinical response to risperidone A LLerena, R Berecz, E Peñas-LLedó, Á Süveges, H Farinas Pharmacogenomics 14 (2), 177-194, 2013 | 45 | 2013 |
| Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotypes in diclofenac urinary metabolic ratios P Dorado, R Berecz, MC Cáceres, A LLerena Journal of Chromatography B 789 (2), 437-442, 2003 | 40 | 2003 |
